Open user controls
- Log In Using Your Account
  Log In
  
  Don't have an account? Sign Up Today

- My Account
- Dashboard
- Profile
- Saved items
- Logout

68°
- Benton, AR (72018)
  Today
  
  Cloudy with periods of rain. Thunder possible. Low 63F. Winds light and variable. Chance of rain 90%..
  
  Tonight
  
  Cloudy with periods of rain. Thunder possible. Low 63F. Winds light and variable. Chance of rain 90%.
  
  Updated: November 20, 2025 @ 3:21 pm
- Full Forecast

- Site search

Home
News
- Local News
Sports
Obituaries
Multimedia
- Photo Galleries
- Videos
e-Edition
Classifieds
Archives
Readers Choice 2025

Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

argenx SE - American Depositary Shares (NQ:ARGX)

918.50 +3.91 (+0.43%)

Streaming Delayed Price Updated: 4:00 PM EST, Nov 20, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about argenx SE - American Depositary Shares

< Previous 1 2

...

8 9 10 11 12 13 14 15 Next >

Earnings Outlook For argenx ↗

March 01, 2023

Via Benzinga

argenx Appoints Steve Krognes to Board of Directors

February 27, 2023

From argenx SE

Via GlobeNewswire

argenx to Present at Upcoming Investor Conferences

February 27, 2023

From argenx SE

Via GlobeNewswire

argenx to Report Full Year 2022 Financial Results and Fourth Quarter Business Update on March 2, 2023

February 23, 2023

From argenx SE

Via GlobeNewswire

Immunovant Could Potentially Be An M&A Target, Writes Analyst ↗

February 15, 2023

Via Benzinga

Analyst Ratings for argenx ↗

January 10, 2023

Via Benzinga

Analyst Ratings for argenx ↗

December 07, 2022

Via Benzinga

Expert Ratings for argenx ↗

December 07, 2022

Via Benzinga

7 Analysts Have This to Say About argenx ↗

October 18, 2022

argenx (NASDAQ:ARGX) has observed the following analyst ratings within the last quarter:

Via Benzinga

Here's What's Next For Biohaven After Its $12 Billion Pfizer Buyout, According To CEO Vlad Coric ↗

February 02, 2023

The company that remains still has a large pipeline of non-migraine assets.

Via Investor's Business Daily

argenx Receives Notification of PDUFA Date Extension for SC Efgartigimod

January 27, 2023

From argenx SE

Via GlobeNewswire

argenx Announces Extraordinary General Meeting of Shareholders on February 27, 2023 to Appoint Steve Krognes as Non-Executive Director

January 16, 2023

From argenx SE

Via GlobeNewswire

AT&T To Rally Over 15%? Here Are 10 Other Analyst Forecasts For Tuesday ↗

January 10, 2023

Keybanc boosted Five Below, Inc. (NASDAQ: FIVE) price target from $188 to $200. Keybanc analyst Bradley Thomas maintained an Overweight rating on the stock. Five Below shares fell 1.6% to $183.92 in...

Via Benzinga

argenx Highlights 2023 Strategic Priorities Across Immunology Pipeline

January 09, 2023

From argenx SE

Via GlobeNewswire

argenx to Present at 41st Annual J.P. Morgan Healthcare Conference

January 03, 2023

From argenx SE

Via GlobeNewswire

Alphabet To $115? Here Are 10 Other Price Target Changes For Thursday ↗

December 22, 2022

Stifel raised argenx SE (NASDAQ: ARGX) price target from $471 to $478. Stifel analyst Alex Thompson maintained a Buy rating on the stock. argenx shares rose 1.1% to $387.07 in pre-market trading.

Via Benzinga

argenx Appoints Ana Cespedes to Board of Directors

December 12, 2022

From argenx SE

Via GlobeNewswire

argenx to Present Pivotal ADVANCE Trial Data During ASH Plenary Session Highlighting VYVGART® (efgartigimod alfa-fcab) as Potential New Treatment Modality for Immune Thrombocytopenia

December 10, 2022

From argenx SE

Via GlobeNewswire

Bluebird Bio Sells Priority Review Voucher For $102M, Strengthening Its Financial Position ↗

November 30, 2022

Via Benzinga

argenx Enters Into Agreement To Acquire Priority Review Voucher

November 30, 2022

From argenx SE

Via GlobeNewswire

Argenx's Flagship Neuromuscular Treatment For Subcutaneous Injection Goes Under Priority FDA Review ↗

November 22, 2022

Via Benzinga

argenx Announces U.S. FDA Acceptance of Biologics License Application for Subcutaneous Efgartigimod in Generalized Myasthenia Gravis with Priority Review

November 22, 2022

From argenx SE

Via GlobeNewswire

Stocks That Hit 52-Week Lows On Thursday ↗

December 01, 2022

During Thursday's session, 108 stocks hit new 52-week highs.

Via Benzinga

argenx to Present at Upcoming Investor Conferences

November 07, 2022

From argenx SE

Via GlobeNewswire

McDonald's To Rally Over 13%? Here Are 5 Other Price Target Changes For Friday ↗

October 28, 2022

Wedbush raised McDonald's Corporation (NYSE: MCD) price target from $265 to $300. Wedbush analyst Nick Setyan maintained the stock with an Outperform rating. McDonald's shares rose 3.3% to close at...

Via Benzinga

Recap: argenx Q3 Earnings ↗

October 27, 2022

argenx (NASDAQ:ARGX) reported its Q3 earnings results on Thursday, October 27, 2022 at 01:00 AM. Here's what investors need to know about the announcement. Earnings argenx missed estimated earnings by...

Via Benzinga

argenx Reports Third Quarter 2022 Financial Results and Provides Business Update

October 27, 2022

From argenx SE

Via GlobeNewswire

argenx to Report Third Quarter 2022 Financial Results and Business Update on October 27, 2022

October 20, 2022

From argenx SE

Via GlobeNewswire

Benzinga's Top Ratings Upgrades, Downgrades For October 12, 2022 ↗

October 12, 2022

Upgrades

Via Benzinga

Immunovant's New Candidate Provides Some Strategic Flexibility & Clarity, Analysts Say ↗

September 29, 2022

Via Benzinga

< Previous 1 2

...

8 9 10 11 12 13 14 15 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Sections

Home
News
Sports
Entertainment
Local Events
Obituaries
Multimedia
Announcements
e-Edition
Online Features

Services

Subscription Services
Submission Forms
Classifieds
Place an Ad
Promote Your Event
Email Alerts
Search
Weather

bentoncourier.com
321 North Market Street
Benton, AR 72018
Phone: 501-315-8228
Email: bcadmin@bentoncourier.com

Facebook
Twitter

Browser Compatibility

Your browser is out of date and potentially vulnerable to security risks.
We recommend switching to one of the following browsers:

Microsoft Edge Google Chrome Firefox

Log In Using Your Account

Benton, AR (72018)

Today

Tonight

argenx SE - American Depositary Shares (NQ:ARGX)

All News about argenx SE - American Depositary Shares

Sections

Services

Follow Us